Shopping Cart 0
Cart Subtotal
USD 0

Steris Plc (STE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and barrier solutions. It also provides detergents and skin care products, laboratory testing, linen management and off-site reprocessing, microbial reduction of medical devices, and chemical and biological decontamination technologies for aircraft, buildings, vehicles, and sensitive equipment. Steris offers its products to medical device, healthcare, pharmaceutical, research and laboratory, and defense and industrial markets. The company markets and sells its products through direct sales force, distributors and dealers in the UK and abroad. Steris is headquartered in Derby, the UK.

Steris Plc (STE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Steris Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9

Steris Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Steris Plc, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Synergy Health Completes Private Placement Of Shares For USD35 Million 11

Debt Offering 12

Steris Raises USD125 Million in Private Placement of 3.45% Notes Due 2025 12

Steris Raises USD100 Million in Priavte Placement of 3.75% Notes Due 2030 13

Steris Raises USD125 Million in Private Placement of 3.55% Notes Due 2027 14

Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2030 15

Steris Raises USD45 Million in Private Placement of 3.07% Notes Due 2023 16

Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2025 17

Steris Raises USD45.5 Million in Private Placement of 3.7% Notes Due 2022 18

Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2027 19

Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2024 20

Acquisition 21

Steris Acquires Synergy Health for USD2.3 Billion 21

Steris Acquires Biotest Labs 23

Steris Plc-Key Competitors 24

Steris Plc-Key Employees 25

Steris Plc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Joint Venture 28

Recent Developments 29

Financial Announcements 29

Aug 08, 2018: STERIS Announces financial results for fiscal 2019 first quarter 29

Feb 07, 2018: STERIS Announces Financial Results for Fiscal 2018 Third Quarter 30

Nov 01, 2017: STERIS Announces Financial Results for Fiscal 2018 Second Quarter 31

Aug 08, 2017: STERIS Announces Financial Results for Fiscal 2018 First Quarter 32

May 09, 2017: STERIS Announces Financial Results for Fiscal 2017 Fourth Quarter and Full Year 33

Feb 07, 2017: STERIS Announces Financial Results for Fiscal 2017 Third Quarter 35

Corporate Communications 37

May 09, 2018: STERIS Announces Changes to Board of Directors 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38


List Of Figure

List of Figures

Steris Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Steris Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Steris Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Steris Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Steris Plc, Deals By Therapy Area, 2012 to YTD 2018 8

Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9

Steris Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Synergy Health Completes Private Placement Of Shares For USD35 Million 11

Steris Raises USD125 Million in Private Placement of 3.45% Notes Due 2025 12

Steris Raises USD100 Million in Priavte Placement of 3.75% Notes Due 2030 13

Steris Raises USD125 Million in Private Placement of 3.55% Notes Due 2027 14

Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2030 15

Steris Raises USD45 Million in Private Placement of 3.07% Notes Due 2023 16

Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2025 17

Steris Raises USD45.5 Million in Private Placement of 3.7% Notes Due 2022 18

Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2027 19

Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2024 20

Steris Acquires Synergy Health for USD2.3 Billion 21

Steris Acquires Biotest Labs 23

Steris Plc, Key Competitors 24

Steris Plc, Key Employees 25

Steris Plc, Subsidiaries 26

Steris Plc, Joint Venture 28

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Steris Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Steris Plc (Steris), formerly Steris Ltd is a medical equipment company that provides infection prevention and other procedural products. The company offers products such as OR integration systems, sterilizers, surgical tables and lights, perioperative solutions, endoscopy accessories and barrier solutions. It also provides detergents and skin care products, laboratory testing, linen management and off-site reprocessing, microbial reduction of medical devices, and chemical and biological decontamination technologies for aircraft, buildings, vehicles, and sensitive equipment. Steris offers its products to medical device, healthcare, pharmaceutical, research and laboratory, and defense and industrial markets. The company markets and sells its products through direct sales force, distributors and dealers in the UK and abroad. Steris is headquartered in Derby, the UK.

Steris Plc (STE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Steris Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9

Steris Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Steris Plc, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Synergy Health Completes Private Placement Of Shares For USD35 Million 11

Debt Offering 12

Steris Raises USD125 Million in Private Placement of 3.45% Notes Due 2025 12

Steris Raises USD100 Million in Priavte Placement of 3.75% Notes Due 2030 13

Steris Raises USD125 Million in Private Placement of 3.55% Notes Due 2027 14

Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2030 15

Steris Raises USD45 Million in Private Placement of 3.07% Notes Due 2023 16

Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2025 17

Steris Raises USD45.5 Million in Private Placement of 3.7% Notes Due 2022 18

Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2027 19

Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2024 20

Acquisition 21

Steris Acquires Synergy Health for USD2.3 Billion 21

Steris Acquires Biotest Labs 23

Steris Plc-Key Competitors 24

Steris Plc-Key Employees 25

Steris Plc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Joint Venture 28

Recent Developments 29

Financial Announcements 29

Aug 08, 2018: STERIS Announces financial results for fiscal 2019 first quarter 29

Feb 07, 2018: STERIS Announces Financial Results for Fiscal 2018 Third Quarter 30

Nov 01, 2017: STERIS Announces Financial Results for Fiscal 2018 Second Quarter 31

Aug 08, 2017: STERIS Announces Financial Results for Fiscal 2018 First Quarter 32

May 09, 2017: STERIS Announces Financial Results for Fiscal 2017 Fourth Quarter and Full Year 33

Feb 07, 2017: STERIS Announces Financial Results for Fiscal 2017 Third Quarter 35

Corporate Communications 37

May 09, 2018: STERIS Announces Changes to Board of Directors 37

Appendix 38

Methodology 38

About GlobalData 38

Contact Us 38

Disclaimer 38


List Of Figure

List of Figures

Steris Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Steris Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Steris Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Steris Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Steris Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Steris Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Steris Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Steris Plc, Deals By Therapy Area, 2012 to YTD 2018 8

Steris Plc, Medical Devices Deals, 2012 to YTD 2018 9

Steris Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Synergy Health Completes Private Placement Of Shares For USD35 Million 11

Steris Raises USD125 Million in Private Placement of 3.45% Notes Due 2025 12

Steris Raises USD100 Million in Priavte Placement of 3.75% Notes Due 2030 13

Steris Raises USD125 Million in Private Placement of 3.55% Notes Due 2027 14

Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2030 15

Steris Raises USD45 Million in Private Placement of 3.07% Notes Due 2023 16

Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2025 17

Steris Raises USD45.5 Million in Private Placement of 3.7% Notes Due 2022 18

Steris Raises USD12.5 Million in Private Placement of 4.05% Notes Due 2027 19

Steris Raises USD40 Million in Private Placement of 3.85% Notes Due 2024 20

Steris Acquires Synergy Health for USD2.3 Billion 21

Steris Acquires Biotest Labs 23

Steris Plc, Key Competitors 24

Steris Plc, Key Employees 25

Steris Plc, Subsidiaries 26

Steris Plc, Joint Venture 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Steris Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.